Presentation on theme: "Bone Marrow Transplant in Oncology. Source Pathology Treat Leukemia by chemotherapy Regeneration of normal marrow Chemotherapy alone cannot eliminate."— Presentation transcript:
Bone Marrow Transplant in Oncology
Pathology Treat Leukemia by chemotherapy Regeneration of normal marrow Chemotherapy alone cannot eliminate all malignant cells Stem cell transplants.
Tranplant Patient's bone marrow stem cells are replaced with healthy cells Existing bone marrow and abnormal leukocytes killed Chemotherapy and radiation Next bone marrow containing healthy stem cells re-infused
Adult Stem Cell Transplant
Procedure Most blood stem cells reside in the bone marrow and a small number are present in the bloodstream Multipotent peripheral blood stem cells Can be obtained from drawn blood PBSCs are easier to collect than bone marrow stem cells
Who can be the donor Bone marrow donors can be any normal person who is willing to donate. Even the comatose patient can be donor. Donor can not be the cadaver. Preferable if siblings or parents can donate. This is done just prior to time of transplant
Graft Verses Host Disease (GVHD) GVHD sometimes occurs with allogeneic transplantation. Lymphocytes from the donor graft attack the cells of the host GVHD can usually be treated with steroids or other immunosuppressive agents. Acute GVHD occurs before day 100 post-transplant Chronic GVHD occurs beyond day 100 Recent advances have reduced the incidence and severity of this post-transplant complication, but GVHD, directly or indirectly, still accounts for approximately 15% of deaths in stem cell transplant patients Chronic GVHD can develop months or even years post-transplant